Pediatric Acute Lung Injury and Sepsis Investigators (PALISI): Evolution of an Investigator-Initiated Research

Adrienne G Randolph1,2, Melania M Bembea3, Ira M Cheifetz4

  • 1Division of Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA.

Insights

The Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network has evolved over 20 years, expanding research beyond sepsis and lung injury to all pediatric critical care. This multidisciplinary network now operates independently, fostering global research and over 350 publications.

Area of Science:

  • Pediatric Critical Care Medicine
  • Clinical Research Networks
  • Translational Research

Background:

  • The Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network was established over two decades ago to advance critical care for infants and children.
  • The network has undergone significant evolution, formalizing its infrastructure and broadening its research scope.
  • PALISI transitioned to an independent, nonprofit 501c3 structure in 2020, enabling greater fundraising and operational flexibility.

Purpose of the Study:

  • To detail the evolution and expansion of the PALISI Network's research focus and organizational structure.
  • To highlight the network's multidisciplinary approach and global collaborations.
  • To showcase the breadth of research areas now encompassed within pediatric critical care.

Main Methods:

  • The network comprises investigators from over 90 pediatric intensive care units (PICUs) in the US and Canada, with international collaborations.
  • Research methodologies span the full spectrum of clinical and translational science, including immunobiology, surveys, consensus conferences, observational studies, case-control studies, and randomized controlled trials.
  • Activities are funded by member subscriptions, supporting infrastructure and future initiatives.

Main Results:

  • PALISI's research focus has expanded from sepsis and acute lung injury to encompass diverse areas such as mechanical ventilation liberation, blood product use, intubation safety, sedation, glucose control, and pandemic research (influenza, COVID-19).
  • The network has published over 350 peer-reviewed publications between 2002 and September 2022.
  • The independent nonprofit structure facilitates investment in infrastructure and broader fundraising opportunities.

Conclusions:

  • The PALISI Network has successfully evolved into an independent, robust research entity.
  • Its expanded research agenda and multidisciplinary, global approach are optimizing the care of critically ill children.
  • The network's comprehensive research strategy is generating significant evidence to inform pediatric critical care practices.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
315
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
283
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
263
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
182
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
423
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
30